Literature DB >> 11388371

The angiotensin-converting enzyme gene as a possible risk or protective factor in Alzheimer's disease.

T V Shcherbatykh1, S A Kiryanov, G I Korovaitseva, N D Selezneva, N I Voskresenskaya, V E Golimbet, L Farrer, S I Gavrilova, E I Rogaev.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11388371     DOI： 10.1023/a:1005264324466

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN： 0097-0549


× No keyword cloud information.
  15 in total

1.  Presenilin polymorphisms in Alzheimer's disease.

Authors:  G I Korovaitseva; A Bukina; L A Farrer; E I Rogaev
Journal:  Lancet       Date:  1997-09-27       Impact factor: 79.321

2.  Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy.

Authors:  G S Zubenko; L Volicer; L K Direnfeld; M Freeman; P J Langlais; R A Nixon
Journal:  Brain Res       Date:  1985-03-04       Impact factor: 3.252

3.  Deletion polymorphism in the angiotensin-converting enzyme gene in patients with a history of ischemic stroke.

Authors:  M Margaglione; E Celentano; E Grandone; G Vecchione; G Cappucci; N Giuliani; D Colaizzo; S Panico; F P Mancini; G Di Minno
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-02       Impact factor: 8.311

4.  Polymorphism of the angiotensin-converting enzyme (ACE) gene in patients with thrombotic brain infarction.

Authors:  Y Doi; M Yoshinari; H Yoshizumi; S Ibayashi; M Wakisaka; M Fujishima
Journal:  Atherosclerosis       Date:  1997-07-25       Impact factor: 5.162

5.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.

Authors:  A Goate; M C Chartier-Harlin; M Mullan; J Brown; F Crawford; L Fidani; L Giuffra; A Haynes; N Irving; L James
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

6.  Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction.

Authors:  L Tiret; F Kee; O Poirier; V Nicaud; L Lecerf; A Evans; J P Cambou; D Arveiler; G Luc; P Amouyel
Journal:  Lancet       Date:  1993-04-17       Impact factor: 79.321

7.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction.

Authors:  F Cambien; O Poirier; L Lecerf; A Evans; J P Cambou; D Arveiler; G Luc; J M Bard; L Bara; S Ricard
Journal:  Nature       Date:  1992-10-15       Impact factor: 49.962

8.  Angiotensin converting enzyme in Alzheimer's disease increased activity in caudate nucleus and cortical areas.

Authors:  A Arregui; E K Perry; M Rossor; B E Tomlinson
Journal:  J Neurochem       Date:  1982-05       Impact factor: 5.372

9.  PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1).

Authors:  B Rigat; C Hubert; P Corvol; F Soubrier
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

10.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.

Authors:  R Sherrington; E I Rogaev; Y Liang; E A Rogaeva; G Levesque; M Ikeda; H Chi; C Lin; G Li; K Holman; T Tsuda; L Mar; J F Foncin; A C Bruni; M P Montesi; S Sorbi; I Rainero; L Pinessi; L Nee; I Chumakov; D Pollen; A Brookes; P Sanseau; R J Polinsky; W Wasco; H A Da Silva; J L Haines; M A Perkicak-Vance; R E Tanzi; A D Roses; P E Fraser; J M Rommens; P H St George-Hyslop
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962
View more
  1 in total

1.  Angiotensin-converting enzyme insertion/deletion polymorphism is not a major determining factor in the development of sporadic Alzheimer disease: evidence from an updated meta-analysis.

Authors:  Xue-bin Wang; Ning-hua Cui; Jie Yang; Xue-ping Qiu; Jia-jia Gao; Na Yang; Fang Zheng
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.